Surmontil
NDC Package 51285-554-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Surmontil is a medication used to treat depression. Marketed by Teva Women's Health, Inc., this product is identified by NDC 51285-554 and is authorized under FDA application NDA016792.

Identification & Billing

NDC Package Code
51285-554-02
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
51285-554
11-Digit Billing Format
51285055402
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Surmontil
Dosage Form
-
Usage Information
This medication is used to treat depression. It may help improve your mood and sense of well-being and allow you to enjoy everyday life more. Trimipramine is a tricyclic antidepressant. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

Regulatory & Marketing

Labeler Name
Teva Women's Health, Inc.
FDA Application #
NDA016792
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-30-1990
End Marketing Date
04-30-2020
Listing Expiration
04-30-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51285-554-02 identifies a specific commercial package of 100 capsule in 1 bottle of Surmontil, labeled by Teva Women's Health, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Teva Women's Health, Inc. on September 30, 1990. The current certification is valid through April 30, 2020.

What are the primary indications for this medication?

This medication is used to treat depression. It may help improve your mood and sense of well-being and allow you to enjoy everyday life more. Trimipramine is a tricyclic antidepressant. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.

How is this Teva Women's Health, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51285055402. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51285-554-02
11-Digit CMS (5-4-2)
51285-0554-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.